Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « P. Sève »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
P. Spuls < P. Sève < P. Thomann  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000139 (2018) E. Diwo [France] ; P. Sève [France] ; S. Trad [France] ; P. Bielefeld [France] ; D. Sène [France] ; S. Abad [France] ; A. Brézin [France] ; P. Quartier [France] ; I. Koné Paut [France] ; M. Weber [France] ; C. Chiquet [France] ; M H Errera [France] ; J. Sellam [France] ; P. Cacoub [France] ; G. Kaplanski [France] ; L. Kodjikian [France] ; B. Bodaghi [France] ; D. Saadoun [France][Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
000367 (2015) E. Feurer [France] ; P. Bielefeld [France] ; D. Saadoun [France] ; P. Sève [France][Biologics in uveitis].
000506 (2013) D. Saadoun [France] ; B. Bodaghi ; B. Bienvenu ; B. Wechsler ; D. Sene ; S. Trad ; S. Abad ; P. Cacoub ; L. Kodjikian ; P. SèveBiotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Humans
2Antibodies, Monoclonal (therapeutic use)
2Biological Products (therapeutic use)
2Biological Therapy (methods)
2Immunoglobulins, Intravenous (therapeutic use)
2Immunosuppressive Agents (therapeutic use)
2Tumor Necrosis Factor-alpha (immunology)
1Adrenal Cortex Hormones (therapeutic use)
1Animals
1Antibodies, Monoclonal (immunology)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Behcet Syndrome (complications)
1Behcet Syndrome (drug therapy)
1Behcet disease
1Biological Therapy
1Expert Testimony
1Eye Diseases (immunology)
1Eye Diseases (therapy)
1Immunoglobulins, Intravenous (immunology)
1Inflammation (immunology)
1Inflammation (therapy)
1Interferons (therapeutic use)
1Practice Guidelines as Topic (standards)
1Rituximab (therapeutic use)
1Short Survey
1Tumor Necrosis Factor-alpha (antagonists & inhibitors)
1Uveitis (drug therapy)
1Uveitis (etiology)
1Uveitis (therapy)
1adalimumab
1azathioprine
1cancer recurrence
1clinical evaluation
1corticosteroid
1drug effect
1drug indication
1electroretinography
1human
1infliximab
1interferon
1laser flare photometry
1macular edema
1methotrexate
1multimodal imaging
1mycophenolate mofetil
1perimetry
1photometry
1rapamycin
1remission
1tocilizumab
1treatment planning
1uveitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "P. Sève" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "P. Sève" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    P. Sève
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021